Member Info for RuckRover

Well, we've finally been rumbled. There are only two posters on this board - Inan and Aimbig. The rest of us are aliases.
(or should that be ar*es?)

"You never replied btw crackin, did you retire the d1ckpullar alias in the end?"

I never ceases to amaze me that so many people here have convinced themselves that there is only one person not totally in love with this share. Therefore, anyone with any negative view must be the same person with multiple aliases.

"For how many shares?"
£8 bid for the company!

£8

I guess a bit of clout is important not to mention recognition.
Apparently some people get Scancell Holdings (an immunotherapy company destroying tumour) with Scan Holdings (a packaging company canning tuna)

I heard Dr Ranglani as well as being a great formulation scientist makes really good puddings.

The problem is, NOBODY knows what the "sweet spot" will be.

Cleaner,
Could the omicron specific vaccine be Scancell? No.

The whole point of the Scancell vaccine is that is doesn't target specific variants - it works (hopefully) on ALL variants. It will of course be tested against omicron as one of the many variants it should be effective against.

Yes, the word Covidity and the logo are great.
I wonder if anyone has had the commercial nouse to apply for the trademark?

https://lunginstitute.co.za/2021/11/25/covidity-research-participants-needed/

TF,
" I think everyone else is grateful that we have RG available to carry this interim role forward"
What makes you think you have the right to speak on everyone's behalf?
I'm sure there are a wide range of feelings about the appointment from fantastic to disaster and everything in between.
I don't necessarily think it's a disaster (how can if possibly be any worse than it is) but I'm not jumping up and down for joy. As I said when the news came out - look at his track record.

C11,
If your definition of "running" is 1 patient out of 44 dosed, yes.
Otherwise let's be generous and say the Covidity trial with 16 out of 40 jabbed IS "running".

So we have ONE trial running, not in the core business of cancer care but in a disease that people think has been all but eradicated.

It's no wonder investors who piled in on the back of Covidity are leaving - at a loss.

Well, it doesn't look like many backers for this old nag at the moment.

Do you think Lester Piggott could win the Derby on an old nag?

"I don’t think Scancell are just that one trick pony ?"

Alternatively, with no revenue earning products (as highlighted in your link) you could say are yet to learn a trick.

Cleaner,
Sorry, just seen your clarification.
I wish I could only think about my recent average and forget the purchases at 40p + lol

Cleaner,
I was about to post but noticed AB has made the same point.
Redmile average is about 10p and Vulpes around 8p.

C7,
I think the appointment of LD as CEO replacing CH was of great import and had to be conveyed to the market.
RG as a temporary door to door salesman not so much.
Sorry if that sounds dismissive.

TF,
" 'track record of closing deals', did you have any particular deals in mind ?"
What deals?
Exactly!

2032 - pivotal year?